{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:32Z","timestamp":1761520112057,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clcc.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T04:09:28Z","timestamp":1459483768000},"page":"e235-e239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroendocrine Differentiation of a Primary BRAF Mutant Colon Cancer in a Patient With a\u00a0History of Hairy Cell Leukemia"],"prefix":"10.1016","volume":"15","author":[{"given":"Harsh","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Ramirez-Santrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safi","family":"Shahda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2016.03.006_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00042737-200104000-00018","article-title":"Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer","volume":"13","author":"Grabowski","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2016.03.006_bib2","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"Suppl","key":"10.1016\/j.clcc.2016.03.006_bib3","volume":"32","author":"Venook","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2016.03.006_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jnci\/89.19.1448","article-title":"Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas","volume":"89","author":"Vortmeyer","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2016.03.006_bib5","first-page":"386","article-title":"Metastatic vipoma arising from colonic primary tumor","volume":"15","author":"Bradley","year":"1989","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clcc.2016.03.006_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MPA.0b013e31825c53fa","article-title":"Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma)","volume":"42","author":"Bourcier","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2016.03.006_bib7","first-page":"1114","article-title":"Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells","volume":"52","author":"Frucht","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2016.03.006_bib8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM199410273311703","article-title":"Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinoma and endocrine tumors","volume":"331","author":"Virgolini","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2016.03.006_bib9","first-page":"1183","article-title":"Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract","volume":"21","author":"Hejna","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clcc.2016.03.006_bib10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/1097-0142(19921015)70:8<2087::AID-CNCR2820700813>3.0.CO;2-P","article-title":"Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma","volume":"70","author":"Nielsen","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2016.03.006_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2016.03.006_bib12","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-05-0404","article-title":"Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers","volume":"65","author":"Samowitz","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2016.03.006_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3109\/0284186X.2014.895036","article-title":"The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis","volume":"53","author":"Therkildsen","year":"2014","journal-title":"Acta Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002816300317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002816300317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:05:01Z","timestamp":1761519901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002816300317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1533002816300317"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2016.03.006","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine Differentiation of a Primary BRAF Mutant Colon Cancer in a Patient With a\u00a0History of Hairy Cell Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}